Thank you 2019 Half-Marathon Team Life Without Lupus! News Update Thanks to the Lupus Research Alliance Team Life Without Lupus, with runners who pounded the pavements at the United...
LRA-Supported Researchers Developed a Model to Predict Full-Blown Lupus Nephritis Down the Road News Update A new study funded by the Lupus Nephritis Trials Network with support from the Lupus Research Alliance has proposed...
Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Retrospective Study on Prevalence, Associated Factors and Outcome News Update A new study published in the peer-reviewed journal Lupus shows that lupus can cause damage to the peripheral nervous...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation News Update March 13, 2019 NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...
Frailty Measure Predicts Mortality Risk Among People with Lupus News Update March 11, 2019 March 11, 2019 A new study published in Arthritis & Rheumatology by many top lupus clinicians found that a frailty...
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance Press Release NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
Lupus Therapeutics to Test Potential Treatment for Lupus in Takeda Collaboration Press Release New York, NY– March 1. The Lupus Research Alliance and clinical affiliate, Lupus Therapeutics will partner with Takeda Pharmaceutical Company...
Lupus Research Alliance Congratulates NIH on 5-Year AMP Success Press Release February 28, 2019 NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...
Positive Early Results for BIIB059 as New Treatment Strategy News Update February 28, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial News Update February 28, 2019 The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...
Bacteria in the Gut May be a Cause of Lupus and Flares: Shows Study Supported by Lupus Research Alliance Press Release NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease...
Stelara® and Olumiant® Considered Promising by Lupus Expert News Update February 19, 2019 In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided...